English

CStone Announces the First-in-Class Registrational Clinical Trial of Sugemalimab Met its Primary Endpoint in Stage III NSCLC and Plans to Submit a New Drug Application

– Sugemalimab becomes the world’s first anti-PD-1/PD-L1 monoclonal antibody to successfully improve progression-free survival (PFS) in patients with stage III non-small-cell lung cancer (NSCLC) without disease progression after concurrent or sequential chemoradiotherapy – Sugemalimab is also the world’s first anti-PD-1/PD-L1 monoclonal antibody covering both locally advanced/unresectable (stage III) and metastatic (stage…

thaipr.net

28 พ.ค. 64

Viatris Signs Memorandum of Understanding with The Defeat NCD Partnership at the United Nations Institute for Training and Research (UNITAR)

Reveals initial findings of the Viatris sponsored report at a high-level panel discussion Viatris Inc. (NASDAQ: VTRS) and The Defeat-NCD Partnership (DNCD) at The United Nations Institute for Training and Research (UNITAR) today signed a Memorandum of Understanding (MoU), focused on continuing cooperation and jointly utilising and leveraging their existing resources and facilities for programmes […]

thaipr.net

28 พ.ค. 64

RMI Convenes Six Global Banks to Decarbonize Steel

Citi, Goldman Sachs, ING, Societe Generale, Standard Chartered, and UniCredit are working together to develop a climate-aligned finance agreement to support steel sector decarbonization . Several top lenders to the steel sector—Citi, Goldman Sachs, ING, Societe Generale, Standard Chartered, and UniCredit—have come together to define common standards of action for decarbonizing steel through a collective climate-aligned […]

thaipr.net

28 พ.ค. 64
1 … 2,762 2,763 2,764 2,765 2,766 … 3,101

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.